EMD SERONO, INC.

Organization · MA
Hires government relations

Client is a biopharmaceutical company.

Who they hire

2024 · 2 filings · Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
$██,███ / qtrUnlock

What they lobby on

General pharmaceutical coverage and reimbursement issues, issues and activities affecting oncology, neurodegenerative and fertility products. Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 5378: Lower Costs, More Transparency Act, S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 Issues related to commercial delinking of PBMs in H.R.6283 - DRUG Act, S.1542 - DRUG Act H.R.7085 - BIOSECURE Act Issues related to IVF treatments.
Health Issues · 2024 Q2
Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023.
Taxation/Internal Revenue Code · 2024 Q2
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to Part D delinking of PBMs in H.R.2880 - Protecting Patients Against PBM Abuses Act, S.1967 - PBM Act, S. 2973 - The Modernizing and Ensuring PBM Accountability (MEPA) Act, H.R.8261 - Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 5378: Lower Costs, More Transparency Act, S.3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Medicare/Medicaid · 2024 Q2
Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023. H.R.7024 - Tax Relief for American Families and Workers Act of 2024
Taxation/Internal Revenue Code · 2024 Q1
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to Part D delinking of PBMs in H.R.2880 - Protecting Patients Against PBM Abuses Act, S.1967 - PBM Act H.R. 5378: Lower Costs, More Transparency Act, S.3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Medicare/Medicaid · 2024 Q1